Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001453687-24-000102
Filing Date
2024-08-08
Accepted
2024-08-08 07:07:59
Documents
106
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rnac-20240630.htm   iXBRL 10-Q 1425996
2 EX-31.1 exhibit311_6302024.htm EX-31.1 10322
3 EX-31.2 exhibit312_6302024.htm EX-31.2 10264
4 EX-32.1 exhibit321_6302024.htm EX-32.1 9941
  Complete submission text file 0001453687-24-000102.txt   9562643

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rnac-20240630.xsd EX-101.SCH 83331
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rnac-20240630_cal.xml EX-101.CAL 89773
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rnac-20240630_def.xml EX-101.DEF 481302
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rnac-20240630_lab.xml EX-101.LAB 903285
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rnac-20240630_pre.xml EX-101.PRE 712652
109 EXTRACTED XBRL INSTANCE DOCUMENT rnac-20240630_htm.xml XML 1256325
Mailing Address 704 QUINCE ORCHARD RD GAITHERSBURG MD 20878
Business Address 704 QUINCE ORCHARD RD GAITHERSBURG MD 20878 617-923-1400
Cartesian Therapeutics, Inc. (Filer) CIK: 0001453687 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37798 | Film No.: 241185991
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)